MicroRNA-21: From Cancer to Cardiovascular Disease

Title: MicroRNA-21: From Cancer to Cardiovascular Disease

Volume: 11 Issue: 8

Author(s): Virginija Jazbutyte and Thomas Thum

Affiliation:

Keywords: micro-RNAs, miR-21, cancer, cardiovascular disease

Abstract: MicroRNA-21 (miR-21) expression is activated in multiple types of cancers, such as breast, liver, brain, prostate, myometrial cancers but also in cardiovascular disease. MiR-21 regulates a plethora of target proteins which are involved in cellular survival, apoptosis and cell invasiveness. MiR-21 regulation is complex due to an own promoter that is target for various transcription factors and hormones. The consistent miR-21 overexpression under pathophysiological conditions points to miR-21 as a valuable tool for new therapeutic strategies. In this review, we present and analyze current data about miR-21 expression in various pathologies ranging from cancer to cardiovascular disease. Further, miR- 21 regulatory mechanisms and miR-21 downstream targets are discussed. Finally, we highlight the particular role of miR- 21 as a therapeutic target in various diseases.

Cite this article as:

Jazbutyte Virginija and Thum Thomas, MicroRNA-21: From Cancer to Cardiovascular Disease, Current Drug Targets 2010; 11 (8) . https://dx.doi.org/10.2174/138945010791591403